| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2017 | Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy | SHIH-HUNG YANG ; JEN-CHIEH LEE ; JHE-CYUAN GUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; TING-CHUN KUO ; ANN-LII CHENG ; KUN-HUEI YEH | PLoS ONE | 4 | 3 | |
| 2016 | Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer | SHIH-HUNG YANG ; JHE-CYUAN GUO ; KUN-HUEI YEH ; YU-WEN TIEN ; ANN-LII CHENG ; SUNG-HSIN KUO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
| 2021 | C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv | Kuo, Ting-Chun; MING-HSUN WU ; SHIH-HUNG YANG ; Chen, Syue-Ting; Hsu, Tzu-Wen; Jhuang, Jie-Yang; Liao, Ying-Yu; YU-WEN TIEN ; MIN-CHUAN HUANG | Oncogene | 16 | 14 | |
| 2022 | Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma | SHIH-HUNG YANG ; JEN-CHIEH LEE ; BANG-BIN CHEN ; SUNG-HSIN KUO ; CHIUN HSU ; Bai, Li-Yuan | Frontiers in Immunology | 0 | 0 | |
| 2016 | Clinical significance of circulating tumor microemboli as a prognostic marker in patients with pancreatic ductal adenocarcinoma | MING-CHU CHANG ; YU-TING CHANG ; Chen J.-Y.; YUNG-MING JENG ; CHING-YAO YANG ; YU-WEN TIEN ; SHIH-HUNG YANG ; Chen H.-L.; Liang T.-Y.; Wang C.-F.; Lee E.Y.H.P.; Chang Y.-C.; Lee W.-H. | Clinical Chemistry | 69 | 66 | |
| 2022 | Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy | Chen, Yi Lun; CHIAO-LING TSAI ; CHIA-HSIEN CHENG ; CHUN-WEI WANG ; SHIH-HUNG YANG ; YU-WEN TIEN ; SUNG-HSIN KUO | Frontiers in Oncology | 0 | 0 | |
| 2021 | Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling | SUNG-HSIN KUO ; SHIH-HUNG YANG ; Wei, Ming-Feng; Lee, Hsiao-Wei; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH | Cancer cell international | 2 | 2 | |
| 2022 | Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study | Su, Yung-Yeh; Chiang, Nai-Jung; Li, Chung-Pin; Yen, Chia-Jui; SHIH-HUNG YANG ; Chou, Wen-Chi; Chen, Jen-Shi; Chiu, Tai-Jan; Chen, Yen-Yang; Chuang, Shih-Chang; Bai, Li-Yuan; Chiu, Chang-Fang; Peng, Cheng-Ming; Chan, De-Chuan; Chiu, Sz-Chi; Yang, Yi-Hsin; Shan, Yan-Shen; Chen, Li-Tzong | Frontiers in oncology | 2 | 3 | |
| 2012 | Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy | Kuo Y.-H.; CHING-HUNG LIN ; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG ; Huang S.-M.; CHIUN HSU ; YEN-SHEN LU ; ANN-LII CHENG | BMC Cancer | 17 | 15 | |
| 2022 | Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin | Chiu, Tai-Jan; SHIH-HUNG YANG ; Chiu, Sz-Chi; Hsueh, Shun-Wen; Chiang, Nai-Jung; Li, Chung-Pin; Bai, Li-Yuan; Cheng, Fu-Ming; Chuang, Shih-Chang; Shan, Yan-Shen; Chan, De-Chuan; Chen, Li-Tzong; Yen, Chia-Jui; Peng, Cheng-Ming; Su, Yung-Yeh; Chen, Yen-Yang; Chen, Jen-Shi; Chou, Wen-Chi | Journal of hepato-biliary-pancreatic sciences | 1 | 1 | |
| 2009 | Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma | SHIH-HUNG YANG ; ZHONG-ZHE LIN ; SUNG-HSIN KUO ; ANN-LII CHENG | American Journal of Hematology | 1 | 1 | |
| 2011 | Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials | SHIH-HUNG YANG ; Kuo Y.-H.; YU-WEN TIEN ; CHIUN HSU ; CHIH-HUNG HSU ; SUNG-HSIN KUO ; ANN-LII CHENG | Oncology | 13 | 13 | |
| 2021 | Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study | Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG ; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C. | Therapeutic Advances in Medical Oncology | 2 | 4 | |
| 2020 | Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients | SHIH-HUNG YANG ; JHE-CYUAN GUO ; CHIUN HSU ; SUNG-HSIN KUO ; YU-WEN TIEN ; ANN-LII CHENG ; KUN-HUEI YEH | Journal of the Formosan Medical Association | 2 | 2 | |
| 2022 | Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of MSH6: A case report | Peng, Shang-Hsuan; BANG-BIN CHEN ; Kuo, Ting-Chun; JEN-CHIEH LEE ; SHIH HUNG YANG | Frontiers in immunology | 0 | 0 | |
| 2021 | Metabolic Alterations in Pancreatic Cancer Detected by In Vivo 1H-MR Spectroscopy: Correlation with Normal Pancreas, PET Metabolic Activity, Clinical Stages, and Survival Outcome | Chang, Chih-Kai; TIFFANY TING-FANG SHIH ; YU-WEN TIEN ; Chang, Ming-Chu; YU-TING CHANG ; SHIH-HUNG YANG ; MEI-FANG CHENG ; BANG-BIN CHEN | Diagnostics (Basel, Switzerland) | 3 | 3 | |
| 2020 | A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study | Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; SHIH-HUNG YANG ; Hsiao H.-H.; Shen W.-C.; CHIUN HSU ; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T. | European Journal of Cancer | 7 | 7 | |
| 2020 | Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study | Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG ; CHIUN HSU ; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. | Liver International | 5 | 5 | |
| 2018 | Multiparametric PET/MR imaging biomarkers are associated with overall survival in patients with pancreatic cancer | BANG-BIN CHEN ; YU-WEN TIEN ; MING-CHU CHANG ; MEI-FANG CHENG ; YU-TING CHANG ; SHIH-HUNG YANG ; CHIH-HORNG WU ; TING-CHUN KUO ; I-LUN SHIH ; RUOH-FANG YEN ; TIFFANY TING-FANG SHIH | European Journal of Nuclear Medicine and Molecular Imaging | 28 | 27 | |
| 2021 | Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma | SHIH-HUNG YANG ; LI-CHUN LU ; HSIANG-FONG KAO ; BANG-BIN CHEN ; TING-CHUN KUO ; SUNG-HSIN KUO ; YU-WEN TIEN ; Bai, Li-Yuan; ANN-LII CHENG ; KUN-HUEI YEH | Oncoimmunology | 1 | 2 | |
